These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 21326196)

  • 1. Human Ecstasy use is associated with increased cortical excitability: an fMRI study.
    Bauernfeind AL; Dietrich MS; Blackford JU; Charboneau EJ; Lillevig JG; Cannistraci CJ; Woodward ND; Cao A; Watkins T; Di Iorio CR; Cascio C; Salomon RM; Cowan RL
    Neuropsychopharmacology; 2011 May; 36(6):1127-41. PubMed ID: 21326196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human ecstasy (MDMA) polydrug users have altered brain activation during semantic processing.
    Watkins TJ; Raj V; Lee J; Dietrich MS; Cao A; Blackford JU; Salomon RM; Park S; Benningfield MM; Di Iorio CR; Cowan RL
    Psychopharmacology (Berl); 2013 May; 227(1):41-54. PubMed ID: 23241648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced cortical gray matter density in human MDMA (Ecstasy) users: a voxel-based morphometry study.
    Cowan RL; Lyoo IK; Sung SM; Ahn KH; Kim MJ; Hwang J; Haga E; Vimal RL; Lukas SE; Renshaw PF
    Drug Alcohol Depend; 2003 Dec; 72(3):225-35. PubMed ID: 14643939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MDMA use is associated with increased spatial BOLD fMRI visual cortex activation in human MDMA users.
    Cowan RL; Haga E; deB Frederick B; Dietrich MS; Vimal RL; Lukas SE; Renshaw PF
    Pharmacol Biochem Behav; 2006 Jun; 84(2):219-28. PubMed ID: 16782178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prior MDMA (Ecstasy) use is associated with increased basal ganglia-thalamocortical circuit activation during motor task performance in humans: an fMRI study.
    Karageorgiou J; Dietrich MS; Charboneau EJ; Woodward ND; Blackford JU; Salomon RM; Cowan RL
    Neuroimage; 2009 Jul; 46(3):817-26. PubMed ID: 19264142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of ecstasy [3,4-methylenedioxymethamphetamine (MDMA)] on cerebral blood flow: a co-registered SPECT and MRI study.
    Chang L; Grob CS; Ernst T; Itti L; Mishkin FS; Jose-Melchor R; Poland RE
    Psychiatry Res; 2000 Feb; 98(1):15-28. PubMed ID: 10708923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroimaging research in human MDMA users: a review.
    Cowan RL
    Psychopharmacology (Berl); 2007 Jan; 189(4):539-56. PubMed ID: 16847678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methodological weaknesses in non-randomized studies of ecstasy (MDMA) use: a cautionary note to readers and reviewers.
    Krebs TS; Johansen PØ
    Neuropsychopharmacology; 2012 Mar; 37(4):1070-1; author reply 1072-3. PubMed ID: 22327903
    [No Abstract]   [Full Text] [Related]  

  • 9. Evidence for chronically altered serotonin function in the cerebral cortex of female 3,4-methylenedioxymethamphetamine polydrug users.
    Di Iorio CR; Watkins TJ; Dietrich MS; Cao A; Blackford JU; Rogers B; Ansari MS; Baldwin RM; Li R; Kessler RM; Salomon RM; Benningfield M; Cowan RL
    Arch Gen Psychiatry; 2012 Apr; 69(4):399-409. PubMed ID: 22147810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positron emission tomographic evidence of toxic effect of MDMA ("Ecstasy") on brain serotonin neurons in human beings.
    McCann UD; Szabo Z; Scheffel U; Dannals RF; Ricaurte GA
    Lancet; 1998 Oct; 352(9138):1433-7. PubMed ID: 9807990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MDMA (ecstasy) use is associated with reduced BOLD signal change during semantic recognition in abstinent human polydrug users: a preliminary fMRI study.
    Raj V; Liang HC; Woodward ND; Bauernfeind AL; Lee J; Dietrich MS; Park S; Cowan RL
    J Psychopharmacol; 2010 Feb; 24(2):187-201. PubMed ID: 19304866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mapping serotonergic dysfunction in MDMA (ecstasy) users using pharmacological MRI.
    Schouw ML; Gevers S; Caan MW; Majoie CB; Booij J; Nederveen AJ; Reneman L
    Eur Neuropsychopharmacol; 2012 Aug; 22(8):537-45. PubMed ID: 22209360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective.
    Thomasius R; Zapletalova P; Petersen K; Buchert R; Andresen B; Wartberg L; Nebeling B; Schmoldt A
    J Psychopharmacol; 2006 Mar; 20(2):211-25. PubMed ID: 16510479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of dose, sex, and long-term abstention from use on toxic effects of MDMA (ecstasy) on brain serotonin neurons.
    Reneman L; Booij J; de Bruin K; Reitsma JB; de Wolff FA; Gunning WB; den Heeten GJ; van den Brink W
    Lancet; 2001 Dec; 358(9296):1864-9. PubMed ID: 11741626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebral activation in abstinent ecstasy (MDMA) users during a working memory task: a functional magnetic resonance imaging (fMRI) study.
    Daumann J; Fimm B; Willmes K; Thron A; Gouzoulis-Mayfrank E
    Brain Res Cogn Brain Res; 2003 May; 16(3):479-87. PubMed ID: 12706227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional Magnetic Resonance Imaging in Abstinent MDMA Users: A Review.
    Garg A; Kapoor S; Goel M; Chopra S; Chopra M; Kapoor A; McCann UD; Behera C
    Curr Drug Abuse Rev; 2015; 8(1):15-25. PubMed ID: 25731754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MDMA (Ecstasy) association with impaired fMRI BOLD thalamic coherence and functional connectivity.
    Salomon RM; Karageorgiou J; Dietrich MS; McLellan JY; Charboneau EJ; Blackford JU; Cowan RL
    Drug Alcohol Depend; 2012 Jan; 120(1-3):41-7. PubMed ID: 21807471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MDMA ("Ecstasy") and its association with cerebrovascular accidents: preliminary findings.
    Reneman L; Habraken JB; Majoie CB; Booij J; den Heeten GJ
    AJNR Am J Neuroradiol; 2000; 21(6):1001-7. PubMed ID: 10871002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positron emission tomographic studies of brain dopamine and serotonin transporters in abstinent (+/-)3,4-methylenedioxymethamphetamine ("ecstasy") users: relationship to cognitive performance.
    McCann UD; Szabo Z; Vranesic M; Palermo M; Mathews WB; Ravert HT; Dannals RF; Ricaurte GA
    Psychopharmacology (Berl); 2008 Oct; 200(3):439-50. PubMed ID: 18661256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroimaging in human MDMA (Ecstasy) users.
    Cowan RL; Roberts DM; Joers JM
    Ann N Y Acad Sci; 2008 Oct; 1139():291-8. PubMed ID: 18991874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.